Current role
Christopher Mutz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Mutz
The proxy statement of Ani Pharmaceuticals Inc reports total compensation of $3,396,694 for Christopher Mutz in fiscal 2025, including a base salary of $471,625. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ani Pharmaceuticals Inc (ANIP)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ani Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Nikhil Lalwani CEO, Board Member
- Patrick D. Walsh CEO, Board Member
- Thomas J. Haughey Chairman
- Stephen Carey CFO
- Muthusamy Shanmugam COO, Board Member
- Meredith W. Cook General Counsel
- Antonio Pera Board Member
- Antonio R. Pera Board Member
- David B. Nash, M.D. Board Member
- Henry Gosebruch Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $471,625 | $3,396,694 |
| 2024 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $447,863 | $2,417,672 |
| 2023 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $424,050 | $1,914,451 |
| 2022 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $408,772 | $1,304,213 |
| 2021 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $338,462 | $1,605,932 |
Recent activity
No call appearances or filed executive changes recorded yet.